Ziyaad Waja to Humans
This is a "connection" page, showing publications Ziyaad Waja has written about Humans.
Connection Strength
0,279
-
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes. Emerg Infect Dis. 2025 Mar; 31(3):467-476.
Score: 0,019
-
The performance of tongue swabs for detection of pulmonary tuberculosis. Front Cell Infect Microbiol. 2023; 13:1186191.
Score: 0,017
-
Exhaled breath specimens subjected to point-of-care lipoarabinomannan testing. Int J Tuberc Lung Dis. 2023 09 01; 27(9):703-705.
Score: 0,017
-
SMA-TB: study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs, acetylsalicylic acid and ibuprofen, for use as adjunct therapy added to, and compared with, the standard WHO recommended TB regimen. Trials. 2023 Jun 28; 24(1):435.
Score: 0,016
-
A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials. Am J Respir Crit Care Med. 2023 05 15; 207(10):1376-1382.
Score: 0,016
-
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349). Clin Infect Dis. 2023 02 08; 76(3):e580-e589.
Score: 0,016
-
Differentially culturable tubercle bacteria as a measure of tuberculosis treatment response. Front Cell Infect Microbiol. 2022; 12:1064148.
Score: 0,016
-
Systemic DPP4/CD26 is associated with natural HIV-1 control: Implications for COVID-19 susceptibility. Clin Immunol. 2021 09; 230:108824.
Score: 0,014
-
Supplementation of sputum cultures with culture filtrate to detect tuberculosis in a cross-sectional study of HIV-infected individuals. Tuberculosis (Edinb). 2021 07; 129:102103.
Score: 0,014
-
Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV. BMC Infect Dis. 2021 May 22; 21(1):466.
Score: 0,014
-
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis. N Engl J Med. 2021 05 06; 384(18):1705-1718.
Score: 0,014
-
Detection of differentially culturable tubercle bacteria in sputum using mycobacterial culture filtrates. Sci Rep. 2021 03 22; 11(1):6493.
Score: 0,014
-
Human leukocyte antigen associations with protection against tuberculosis infection and disease in human immunodeficiency virus-1 infected individuals, despite household tuberculosis exposure and immune suppression. Tuberculosis (Edinb). 2021 01; 126:102023.
Score: 0,014
-
Isoniazid Preventive Therapy and Pregnancy Outcomes in Women Living With Human Immunodeficiency Virus in the Tshepiso Cohort. Clin Infect Dis. 2020 09 12; 71(6):1419-1426.
Score: 0,014
-
Performance of the Roche cobas MTB Assay for the Molecular Diagnosis of Pulmonary Tuberculosis in a High HIV Burden Setting. J Mol Diagn. 2020 10; 22(10):1225-1237.
Score: 0,013
-
Subclinical tuberculosis and adverse infant outcomes in pregnant women with HIV. Int J Tuberc Lung Dis. 2020 07 01; 24(7):681-685.
Score: 0,013
-
Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Pregnant South African Women with Tuberculosis and HIV. Antimicrob Agents Chemother. 2020 02 21; 64(3).
Score: 0,013
-
Chronic HIV-1 Infection Alters the Cellular Distribution of Fc?RIIIa and the Functional Consequence of the Fc?RIIIa-F158V Variant. Front Immunol. 2019; 10:735.
Score: 0,012
-
Poor Obstetric and Infant Outcomes in Human Immunodeficiency Virus-Infected Pregnant Women With Tuberculosis in South Africa: The Tshepiso Study. Clin Infect Dis. 2018 03 05; 66(6):921-929.
Score: 0,011